Australia markets closed

Shockwave Medical, Inc. (SWAV)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
329.84-0.35 (-0.11%)
At close: 04:00PM EDT
331.00 +1.16 (+0.35%)
Pre-market: 04:21AM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 12.38B
Enterprise value 12.16B
Trailing P/E 85.71
Forward P/E 68.97
PEG ratio (5-yr expected) N/A
Price/sales (ttm)17.27
Price/book (mrq)18.51
Enterprise value/revenue 16.65
Enterprise value/EBITDA 63.47

Trading information

Stock price history

Beta (5Y monthly) 0.88
52-week change 318.69%
S&P500 52-week change 323.57%
52-week high 3331.58
52-week low 3157.00
50-day moving average 3297.72
200-day moving average 3232.75

Share statistics

Avg vol (3-month) 31.1M
Avg vol (10-day) 3867.67k
Shares outstanding 537.51M
Implied shares outstanding 637.51M
Float 836.85M
% held by insiders 11.27%
% held by institutions 195.41%
Shares short (15 Apr 2024) 41.47M
Short ratio (15 Apr 2024) 40.73
Short % of float (15 Apr 2024) 45.09%
Short % of shares outstanding (15 Apr 2024) 43.91%
Shares short (prior month 15 Mar 2024) 41.79M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 20.17%
Operating margin (ttm)21.96%

Management effectiveness

Return on assets (ttm)9.38%
Return on equity (ttm)24.96%

Income statement

Revenue (ttm)730.23M
Revenue per share (ttm)19.89
Quarterly revenue growth (yoy)40.90%
Gross profit (ttm)N/A
EBITDA 176.35M
Net income avi to common (ttm)147.28M
Diluted EPS (ttm)3.86
Quarterly earnings growth (yoy)-68.60%

Balance sheet

Total cash (mrq)990.55M
Total cash per share (mrq)26.49
Total debt (mrq)770.61M
Total debt/equity (mrq)115.24%
Current ratio (mrq)11.76
Book value per share (mrq)18.08

Cash flow statement

Operating cash flow (ttm)196.05M
Levered free cash flow (ttm)112.47M